绿新生物科技有限公司于2026年3月2日发布截至2026年2月28日的股份变动月报。公告显示，公司2月期间注册股本与已发行股份合计数均未发生变化。
注册股本方面，公司普通股注册规模保持在50,000,000,000股，面值每股港币0.01元，注册股本总额为港币500,000,000元。截至2月末，公司已发行股份总数为874,120,000股，较上月无新增发行或购回活动。期末库藏股数量为零。
报告显示，公司本月无任何股份期权或股权激励计划变动，亦无其他涉及已发行股份或库藏股票数量的变化。公司同时确认，截至2026年2月28日，其已满足香港联交所对最低公众持股量比例的相关要求。
公告由公司秘书苏智文签署。公司表示，所有股份变动事项均符合香港联交所《上市规则》及相关法律法规。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.